Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis
- PMID: 23137782
- DOI: 10.1016/j.eurpsy.2012.08.002
Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis
Abstract
Introduction: Prevention of psychosis has become a major objective of modern clinical psychiatry. An increasing number of new services have been established in Europe and in the world. The OASIS team has become an established model where clinical practice and research are fully integrated in the field of preventative interventions in psychosis.
Method: Comprehensive analysis of different clinical and service measures describing the 2001-2011 implementation of the OASIS team.
Results: Over the last decade, the OASIS team has received a total of 1102 referrals, mostly young males from ethnic minorities. After the assessment, 35% were diagnosed with an At Risk Mental State (ARMS) while 32% were already psychotic. Within the ARMS, 70% met the inclusion criteria for the attenuated psychotic symptoms subgroup, 1% met the inclusion criteria for the genetic deterioration syndrome, 9% met inclusion criteria for a brief and self-limited intermittent psychotic episode and the others met inclusion criteria for more than one subgroup. Most of them had at least one comorbid diagnosis, mainly relating to anxiety and depressive domains. The majority of the OASIS clients received cognitive behavioural therapy alone or in combination with antidepressants/antipsychotics. Over the 2-year follow-up time, 44 subjects (15.2%) developed a frank psychotic episode.
Conclusions: The OASIS service represents one of the largest and most established prodromal services in the world. The burden of research evidence and the translational impact produced on the clinical practice support the OASIS as a model for the development of similar services.
Copyright © 2012. Published by Elsevier SAS.
Similar articles
-
Outreach and support in South-London (OASIS) 2001-2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis.Eur Neuropsychopharmacol. 2020 Oct;39:111-122. doi: 10.1016/j.euroneuro.2020.08.002. Epub 2020 Sep 10. Eur Neuropsychopharmacol. 2020. PMID: 32921544 Free PMC article.
-
Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state.Eur Psychiatry. 2005 Aug;20(5-6):372-8. doi: 10.1016/j.eurpsy.2005.03.001. Eur Psychiatry. 2005. PMID: 16171652
-
Unmet needs for treatment in 102 individuals with brief and limited intermittent psychotic symptoms (BLIPS): implications for current clinical recommendations.Epidemiol Psychiatr Sci. 2019 Nov 19;29:e67. doi: 10.1017/S2045796019000635. Epidemiol Psychiatr Sci. 2019. PMID: 31739812 Free PMC article.
-
Early psychotic experiences: Interventions, problems and perspectives.Psychiatriki. 2015 Jan-Mar;26(1):45-54. Psychiatriki. 2015. PMID: 25880383 Review.
-
Early psychosis for the non-specialist doctor.BMJ. 2017 Nov 8;357:j4578. doi: 10.1136/bmj.j4578. BMJ. 2017. PMID: 29117966 Review. No abstract available.
Cited by
-
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies.Mol Psychiatry. 2022 Jan;27(1):281-295. doi: 10.1038/s41380-021-01161-7. Epub 2021 Jun 2. Mol Psychiatry. 2022. PMID: 34079068 Free PMC article. Review.
-
Improving outcomes of first-episode psychosis: an overview.World Psychiatry. 2017 Oct;16(3):251-265. doi: 10.1002/wps.20446. World Psychiatry. 2017. PMID: 28941089 Free PMC article.
-
ADHD & Pharmacotherapy: Past, Present and Future: A Review of the Changing Landscape of Drug Therapy for Attention Deficit Hyperactivity Disorder.Ther Innov Regul Sci. 2015 Sep;49(5):632-642. doi: 10.1177/2168479015599811. Ther Innov Regul Sci. 2015. PMID: 26366330 Free PMC article.
-
Altering the course of schizophrenia: progress and perspectives.Nat Rev Drug Discov. 2016 Jul;15(7):485-515. doi: 10.1038/nrd.2016.28. Epub 2016 Mar 4. Nat Rev Drug Discov. 2016. PMID: 26939910 Review.
-
Development and Validation of a Clinically Based Risk Calculator for the Transdiagnostic Prediction of Psychosis.JAMA Psychiatry. 2017 May 1;74(5):493-500. doi: 10.1001/jamapsychiatry.2017.0284. JAMA Psychiatry. 2017. PMID: 28355424 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous